INTRODUCTION
============

Lamins are type V intermediate-filament proteins found in the nucleus of metazoan cells ([@B18]; [@B4]; [@B24]). The lamins are structurally conserved, and many animals have two classes of lamin, A and B type, which arise from separate genes. In humans, *LMNA* encodes for all A-type lamins, whereas two separate genes, *LMNB1* and *LMNB2*, encode for B-type lamins. A number of human diseases are caused by mutations in these genes. For example, mutations in *LMNA* can cause dilated cardiomyopathy, Emery--Dreifuss muscular dystrophy, and Hutchinson--Gilford progeria, among others ([@B2]; [@B20]; [@B17]; [@B19]). Of interest, many of these diseases are tissue restricted, with adipose tissue, brain, heart, and skeletal muscle being more sensitive to perturbations in lamin proteins. The basis for this remains unclear.

Recent studies of B-type lamin highlight the importance of these proteins in organogenesis of the developing mouse embryo. Unlike lamin-A, lamin-B1 (Lb1) is essential for postnatal life, and developing *Lmnb1* (*Lb1*)*-*null embryos show defective organogenesis of the brain, diaphragm, and lung ([@B65]; [@B12]; [@B37]). An insertional mutant that produces only the N-terminal half of Lb1 also revealed a role in bone development ([@B68]). The developmental defect in the brain, which was best characterized, appeared as a disorganization of brain cortical layers and was attributed to defective interkinetic nuclear migration, neuronal cell migration, and spindle orientation in neural progenitor cells ([@B12]; [@B37]).

Although lamins appear to be nonessential for cell viability, many processes, including transcriptional/chromatin regulation, mitotic spindle morphology or orientation, signal transduction, cell morphology/migration, and others, are affected by defects in these proteins ([@B31]; [@B67]; [@B52]; [@B25]; [@B58]; [@B30]; [@B12]; [@B37], [@B38]; [@B8]; [@B27]; [@B28]; [@B76]). Further, B-type lamin level is regulated in processes such as aging and cell stress and upon senescence, which can contribute to certain cellular responses, such as inflammation ([@B59]; [@B21]; [@B10]; [@B66]). How lamins function in these various contexts is not well understood, but it is generally accepted that lamins influence nuclear shape and the migratory behavior of cells ([@B15]). Alteration in nuclear shape, often seen as a structural blebbing, is perhaps the most common in vitro phenotype in lamin mutants and has been documented in vivo ([@B65]; [@B48]; [@B26]; [@B23]; [@B68]; [@B40]; [@B34]). However, nuclear deformation also occurs as part of normal cell biology during cell migration and is modulated by nuclear stiffness and lamin-A levels ([@B41]; [@B60]; [@B72]; [@B16]; [@B55]; [@B42]). Accordingly, defective migration is seen in different lamin mutant cell lines in vitro and in *Lb1*-null neuronal populations in vivo ([@B45]; [@B12]; [@B37], [@B36]; [@B54]; [@B6]), but it remains unclear how nuclear shape changes are correlated with cell migratory behavior in vivo.

During heart development, cells migrate from an extracardiac outgrowth called the proepicardial organ at approximately embryonic day 9.0 (E9.0) and populate the surface of the heart by E11.0 ([@B53]; [@B69]). These cells, called epicardial cells, form a continuous epithelial sheet (epicardium) surrounding the myocardium and have been identified by their expression of Wilm's tumor 1 (Wt1), T-box 18 (Tbx18), Tcf21, Scleraxis (Scx), or Semaphorin3D (Sema3D; [@B51]; [@B5]; [@B35]). Epicardial cells contribute to heart development in two main ways. First, factors derived from the epicardium promote myocardial growth and the development of coronary vasculature ([@B11]; [@B64]; [@B43]; [@B50]; [@B13]; [@B74]; [@B49]). Second, a subset of epicardial cells can undergo an epithelial-to-mesenchymal transition (EMT) and migrate into the myocardium, where they can then differentiate into cardiac fibroblasts, vascular smooth muscle, and possibly coronary endothelial cells ([@B71]; [@B61]; [@B35]). Different signaling pathways influence epicardial cell migration ([@B43]; [@B13]; [@B49]; [@B73]; [@B70]). In this study, we describe a defect in the timing of epicardial cell migration and nuclear morphology change during embryonic heart development in mice with germline knockout of *Lb1*. This work highlights the importance of Lb1 in cell morphology and migratory behavior, as well as the use of the developing epicardium as a model for the study of these cell biological phenomena both in vivo and in vitro.

RESULTS AND DISCUSSION
======================

*Lb1*-null epicardial cell explants exhibit an in vitro migration defect
------------------------------------------------------------------------

Previous studies found neuronal migration defects in *Lb1*-null embryos ([@B12]; [@B37]), but because migration is difficult to assay using cultured differentiating neuronal cells, we sought to examine this phenotype in a system more amenable to both in vitro and in vivo analysis. Epicardial cells are an ideal model system for this, as they can be readily explanted, and their biology is fairly well characterized in vivo. To examine migration, we explanted epicardial cells and performed either a wound-healing or Transwell chamber migration assay ([@B3]; [@B47]; [@B1]). Epicardial cells were isolated from E12.5 heart ventricles as a highly enriched population of Wt1-expressing cells ([Figure 1, A--H](#F1){ref-type="fig"}) and the number of explanted cells was similar among *Lb1*^+/+^, *Lb1*^+/−^, and *Lb1*^−/−^ genotypes ([Figure 1I](#F1){ref-type="fig"}). In the scratch wound-healing assay, we measured the closure of the wound by live imaging at the indicated time points. As shown in [Figure 1, J--O](#F1){ref-type="fig"}, wild-type epicardial cells closed the wound faster than *Lb1*-null epicardial cells. A quantitative assessment of three independent explants for each genotype ([Figure 1P](#F1){ref-type="fig"}) shows that this defect becomes apparent around 8 h after wounding. To test this orthogonally, we measured the ability of epicardial cells from *Lb1*^+/+^, *Lb1*^+/−^, and *Lb1*^−/−^ embryos to spontaneously migrate in a Transwell chamber assay. We observed that the number of *Lb1*^+/−^ epicardial cells that migrated was similar to wild type, indicating that haploinsuffiency had little effect on migratory ability, whereas *Lb1*-null epicardial cells showed a significant reduction in the number of migrated cells ([Figure 1Q](#F1){ref-type="fig"}). This result was consistent with our wound-healing assay, and we concluded that *Lb1* was necessary for efficient migration of epicardial cells in vitro.

![*Lb1*-null epicardial cells show a migration defect in vitro. Representative images of wild-type (A--D) and *Lb1*^−/−^ (E--H) E12.5 epicardial explants stained as indicated. Scale bar, 25 μm. (I) Quantitation of the number of *Lb1*^+/+^ *Lb1*^+/−^, and *Lb1*^−/−^ epicardial cells obtained from the explant procedure (at least four explants). Error bars present SEM. (J--O) Representative images from the wound-healing assay using wild-type (J--L) and *Lb1*-null (M--O) epicardial cells. (P) The area between the wounds was measured from three independent samples at the indicated time points, and the mean was plotted (the error bars represent SD). (Q) Quantification of migration of wild-type, *Lb1*^+/−^, and *Lb1*^−/−^ epicardial cells assessed using a Transwell chamber assay from three independent experiments. Error bars represent SD of the mean.](3956fig1){#F1}

Delayed in vivo epicardial cell migration in *Lb1*-null embryos
---------------------------------------------------------------

Epicardial cells encompass the heart by E11.0, undergo EMT, and migrate into the heart at ∼E12.5, where they can later give rise to various cell types ([@B50]; [@B71]; [@B61]; [@B75]; [@B35]; [@B56]). To investigate the possibility of an in vivo migration defect, we imaged confocal stacks from wild-type and *Lb1*-null heart sections at either E13.5 or E15.5 and quantitated the number of Wt1^+^ epicardial cells in the ventricular myocardium. We present the data as a percentage of the total number of Wt1^+^ cells observed. We excluded Wt1^+^ cells from the interventricular septum because of their uncertain origin ([@B56]). As shown in [Figure 2, A--F](#F2){ref-type="fig"}, embryos lacking *Lb1* showed a consistent reduction in the number of Wt1^+^ cells present in the myocardium at E13.5 (white arrowheads). Approximately 30% of the total Wt1^+^ cell population could be found in the wild-type ventricular myocardium, whereas *Lb1*-null embryos had ∼15% ([Figure 2G](#F2){ref-type="fig"}). We did not observe any difference in the number of Wt1^+^ cells on the surface of the heart between the two genotypes, which was consistent with what we observed in our explants. In line with previous reports, Wt1^+^ cells were abundant in the heart myocardium at E15.5 ([@B56]). Of interest, the number of Wt1^+^ cells in the myocardium was similar (∼70% of total) for both genotypes at E15.5 ([Figure 3, H--M and N](#F3){ref-type="fig"}). These results suggest that the Lb1 helps to ensure timely epicardial cell migration in vivo.

![A reduced number of Wt1+ epicardial cells in the myocardium in vivo. (A--C) Wild-type E13.5, (D--F) *Lb1*^−/−^ E13.5, (H--J) wild-type E15.5, and (K--M) *Lb1*^−/−^ E15.5 sections were stained for DAPI and Wt1 as indicated. Representative images of the right ventricle (RV). Myocardial Wt1^+^ cells were quantitated from (G) E13.5 and (N) E15.5 confocal stacks and are presented as percentage of the total number of Wt1^+^ cells. Error bars represent SD. At least 300 Wt1^+^ cells were counted from three independent samples. Scale bars, 50 μm.](3956fig2){#F2}

![Epicardial cells from *Lb1*^−/−^ embryos show a delayed change in nuclear shape. (A--C) Wild-type embryos (E13.5) stained for DAPI (DNA) and Wt1 (epicardial cell marker) and the resulting merge image as indicated. Colocalization of DAPI and Wt1 appears magenta. (D--F) E13.5 *Lb1*^−/−^ embryos were stained as described for wild type. (G--I) Wild-type and (J-L) *Lb1*^−/−^ embryos at E15.5 were stained as described. Quantitation of epicardial cell nuclear width/height in (M) wild-type and (N) *Lb1*^−/−^ hearts. Width was measured parallel to the heart surface, and height was measured perpendicular to the heart surface. The asterisk indicates an example of the flattened morphology and the double asterisk an example of the round morphology. Distribution of nuclear width/height is shown for (O) E13.5 and (P) E15.5. Wild-type samples are gray bars, and *Lb1*^−/−^ embryos are black bars. Three independent embryos were assessed, and at least 50 epicardial cells were quantitated from each embryo. Scale bars, 50 μm. Arrowheads point to examples of Wt1^+^ epicardial cells with different morphologies. RA, right atrium; RV, right ventricle.](3956fig3){#F3}

Altered nuclear morphology in *Lb1*-null epicardial cell in vivo
----------------------------------------------------------------

A previous study observed that mouse epicardial cells on the myocardium adopt a flattened cell and nuclear morphology in vivo ([@B39]). As seen in [Figure 3, A--C](#F3){ref-type="fig"}, many Wt1-marked epicardial cell nuclei surrounding the ventricles and atria adopted a flattened nuclear morphology (arrowheads) in wild-type embryos at E13.5. By contrast, epicardial cells from similar areas of the *Lb1*-null E13.5 heart displayed an increased number of cells with a round, nuclear morphology ([Figure 3, D--F](#F3){ref-type="fig"}, arrowheads). Quantitation of the nuclear width/height ([Figure 3, M and N](#F3){ref-type="fig"}) from wild-type and *Lb1*-null Wt1^+^ epicardial cells that surrounded the ventricles showed that nuclear morphology was indeed different for many E13.5 epicardial cells ([Figure 3O](#F3){ref-type="fig"}). To examine the possibility of an effect of the *Lb1*-null genotype on other nuclear envelope components in epicardial cells, we stained wild-type and *Lb1*-null E13.5 hearts for both lamin A/C and Wt1. As seen in Supplemental [Figure 1, A--H](#F1){ref-type="fig"}, both wild-type and *Lb1*-null epicardial cells showed similar lamin A/C staining. We note that populations of round Wt1^+^ cells were abundant in the caudal region of the ventricles in both wild-type and *Lb1*-null E13.5 animals (Supplemental Figure S1I).

We next asked whether the difference in nuclear morphology was transient. Examining Wt1^+^ epicardial cells from wild-type and *Lb1*-null embryos at E15.5 revealed that the nuclear morphology appeared to be similar ([Figure 3, G--L](#F3){ref-type="fig"}), and quantitative measurement of nuclear width/height revealed only a subtle difference between the two genotypes ([Figure 3P](#F3){ref-type="fig"}). To rule out a technical artifact, we used a different fixation method (Bouin's fixative) and paraffin embedment of our samples. In agreement with our finding, we observed that epicardial cell nuclei from *Lb1*-null embryos were rounder than wild-type counterparts at E13.5 (Supplemental [Figure 1, J and K](#F1){ref-type="fig"}). Explanted *Lb1*-null epicardial cells showed occasional blebbing in vitro, which was apparent by 4′,6-diamidino-2-phenylindole (DAPI), but with no other obvious defects (Supplemental Figure S1, L and M). These data suggest that Lb1 loss results in a delayed morphological change in epicardial cells in vivo.

*Lb1*-null embryos show poor growth of the compact myocardium and incomplete development of the smooth muscle cell layer surrounding the coronary vessels
---------------------------------------------------------------------------------------------------------------------------------------------------------

The ventricular myocardium increases in thickness between E11.5 and E14, and since the epicardium contributes to embryonic myocardial growth, we examined the possibility of a defect in compact myocardium development in *Lb1*-null embryos ([@B11]; [@B64]; [@B43]; [@B50]; [@B49]; [@B57]). Hematoxylin and eosin staining of paraffin-embedded sections revealed that the ratio of ventricular compact myocardium (marked by white double-headed arrows) to overall heart diameter was roughly equal at E12.5 ([Figure 4, A and B](#F4){ref-type="fig"}) but was lower in E16.5 *Lb1*-null embryos compared with wild type ([Figure 4, C--E](#F4){ref-type="fig"}). Although we cannot rule out effects of the germline *Lb1*-null genotype on cardiomyocytes and other cells of the heart, it is possible that epicardial cell migratory defects contribute to the delayed stimulation of myocardial growth. Future work is needed to distinguish between these possibilities. As described previously, *Lb1*-null embryos were smaller and failed to develop to a weight that was comparable to that of wild type ([@B37]; Supplemental Figure S2, A and B).

![*Lb1*^−/−^ embryos show a reduced compact myocardium layer and discontinuous smooth muscle surrounding the coronary vessels. Comparison of compact myocardium thickness (white double-headed arrows) stained with hematoxylin and eosin from E12.5 (A) wild-type and (B) *Lb1*^−/−^ and E16.5 (C) wild-type and (D) *Lb1*^−/−^ embryos. Scale bar, 100 μm. (E) Quantification of compact myocardium thickness normalized to heart diameter. Quantification was performed on at least six different embryos. Error bars indicate SD of the mean. (F--H) Wild- type E18.5 embryos were stained for CD31 (endothelial cell) and smooth muscle actin ("sm actin"; smooth muscle cell) and merged as indicated. (I--K) *Lb1*^−/−^ E18.5 embryos were stained as described for wild type. Arrowheads point to examples of fragmented staining. Scale bar, 25 μm. (L) Quantitation of the mean percentage of coronary vessels with continuous smooth muscle staining from at least three wild-type and *Lb1*^−/−^ E18.5 samples. Error bars represent SD of the mean. Smooth muscle actin staining was classified as either 1) continuous staining around the vessel in at least two consecutive sections or 2) discontinuous staining in at least two consecutive sections.](3956fig4){#F4}

Epicardial cells are believed to give rise to \>90% of the cardiac vascular smooth muscle cells that surround the coronary vessels ([@B50]; [@B71]; [@B5]). We therefore speculated that the migratory delay might lead to a deficiency in vascular smooth muscle cell development. To examine this, we stained E18.5 hearts from wild-type and *Lb1*-null embryos for markers of endothelial cells (CD31) and smooth muscle cells (smooth muscle actin) and imaged a confocal *z*-series for analysis. As seen in [Figure 4, F--H](#F4){ref-type="fig"}, wild-type embryos showed continuous smooth muscle actin staining around the coronary vessel, whereas *Lb1*-null embryos often had fragmented or incomplete smooth muscle actin staining ([Figure 4, I--K](#F4){ref-type="fig"}). Quantitation for vessels with continuous smooth muscle actin staining (defined as a continuous staining in at least two consecutive *z*-images; [Figure 4L](#F4){ref-type="fig"}) showed that ∼75% of wild-type coronary vessels had continuous staining, whereas only ∼20% of the coronary vessels in *Lb1*-null embryos met this criterion. These results indicate that *Lb1*-null embryos have poor development of the compact myocardial layer and incomplete formation of vascular smooth muscle around coronary vessels. This suggests that the epicardial layer is one source of the observed defects.

Gene expression change in *Lb1*-null epicardial cells
-----------------------------------------------------

Lb1 has been shown to influence the expression of certain genes, some of which may contribute to cell migration ([@B18]). To explore this possibility, we performed triplicate RNA-sequencing experiments on wild-type and *Lb1*-null epicardial cell explants and considered a gene to be affected by *Lb1* loss only if the change was observed in all three replicates. We found that *Lb1* loss in epicardial cells resulted in the transcriptional up- and down-regulation of 122 and 160 genes, respectively. DAVID Gene Ontology (GO) analyses showed that many up-regulated GO terms were related to immune response function ([Figure 5A](#F5){ref-type="fig"}). Of interest, both *Lb1* reduction and increased secretion of proinflammatory cytokines and chemokines are linked to cell senescence ([@B14]; [@B21]). In addition, in the *Drosophila* fat body, both age-associated lamin-B (*Drosophila* only has one B-type lamin) reduction and genetic knockdown of lamin-B in young flies increased the expression of immune-responsive genes and systemic inflammation ([@B9]). Taken together, these findings suggest that lamin-B is involved in repressing immune-responsive genes during embryonic development and adult stages.

![*Lb1* loss affects gene expression in epicardial cells. DAVID GO term analysis for (A) up-regulated and (B) down-regulated genes from Lb1-null epicardial explants compared with that of the wild type. (C) Examples of up-regulated (light background) and down-regulated (dark background) genes. (D) qRT-PCR validation of select deregulated genes from three independent wild-type and *Lb1*^−/−^ epicardial cell explants. Error bars indicate SD; \**p* \< 0.05.](3956fig5){#F5}

The most significant down-regulated GO terms are related to cell adhesion and the extracellular matrix function, categories relevant to cell migration ([Figure 5B](#F5){ref-type="fig"}). Of note, we also observed the transcriptional up-regulation of extracellular protease modulators (Serpinb9b, Tfpi2; [Figure 5C](#F5){ref-type="fig"}), which have known roles in cell migration ([@B22]; [@B46]). Further, some modulators of the transforming growth factor β (TGFβ) pathway, which are important to epicardial cell biology and migration, were deregulated. These included Noggin (*Nog*), an inhibitor of TGFβ signaling; *Adamtsl2*, a regulator of TGFβ availability; and Periostin (*Postn*), a downstream target of TGFβ signaling that is linked to the migration of epicardial cells ([Figure 5C](#F5){ref-type="fig"}; [@B13]; [@B44]; [@B63]; [@B62]; [@B32]; [@B77]). As validation, we performed quantitative reverse transcriptase PCR (qRT-PCR) analyses of select genes involved in TGFβ signaling ([Figure 5D](#F5){ref-type="fig"}). Thus *Lb1* loss appears to affect the transcription of a set of genes with importance to cell migratory behavior and likely contributes to the observed migratory delay.

Conclusion
----------

In this study, we identified a delay in epicardial cell migration in *Lb1*-null embryos that was recapitulated in vitro using explanted epicardial cells. Further, *Lb1*-null embryos showed a delayed change in epicardial cell nuclear morphology, which is not well understood in this context and was not apparent in vitro. Instead, explanted epicardial cells lacking Lb1 were largely normal except for the presence of a minor population of cells with nuclear membrane blebbing, a hallmark of some lamin mutant cells cultured in vitro. Considering the cellular roles of Lb1, we speculate that a timely nuclear morphology change in the epicardium, which may contribute to proper expression of certain genes, including those involved in cell adhesion, might be important for cell migration behavior. Alternatively, Lb1 may regulate these genes by influencing the three-dimensional chromatin organization. Although we did not observe an obvious detachment of the epicardium from the hearts of *Lb1*^−/−^ embryos, we cannot rule out the possibility of other changes in the extracellular matrix, or the remodeling thereof, that are beyond the limits of detection. Additional, nontranscriptional roles for Lb1 should be considered, as they are known to be important for cell migration. For instance, Lb1 levels modulate the rebound elasticity of the nucleus during cell migration and also helps to connect the nucleus to the cytoskeleton via the Linker of Nucleoskeleton to Cytoskeleton (LINC) complex ([@B33]; [@B60]; [@B29]; [@B7]). Overall our work highlights the importance of Lb1 to cell migratory behavior and also demonstrates the use of the epicardial cell system to study changes in cell morphology and migration both in vivo and in vitro. This system should be valuable for the further elucidation of the relationship between these cell biological phenomena.

MATERIALS AND METHODS
=====================

Animals
-------

All animal work was done in accordance with the guidelines set forth by the Carnegie Institution Animal Care and Use Committee. *Lb1*-knockout mouse model was previously described ([@B37]). Mice were housed under a 12-h/12-h light/dark cycle and fed ad libitum. Dams were killed by either cervical dislocation or CO~2~ asphyxiation.

Histology
---------

Embryos were isolated at the indicated times and fixed in 4% Formalin for 24 h at 4°C before embedding in either paraffin or O.C.T. (Tissue Tek, Torrance, CA). Before O.C.T. embedding, embryos were saturated in 30% sucrose for 24 h at 4°C. Paraffin-embedded sections were prepared and dehydrated before hematoxylin and eosin staining. O.C.T.-embedded sections were used for immunofluorescence (described later).

Immunofluorescence
------------------

O.C.T.-embedded sections were cut on a Leica CM3050S cryostat to a 10--12 μm thickness and attached to Superfrost microscope slides (12-550-15; Fisher, Rockford, MA). Heat-induced antigen retrieval was done with sodium citrate, pH 6.0, supplemented with Tween-20. Retrieved sections were permeabilized with phosphate-buffered saline (PBS) containing 0.25% Triton X-100 and blocked with PBS containing 10% bovine serum albumin, 10% normal goat serum, and M.O.M blocking agent (MKB-2213; Vector Labs, Burlingame, CA). Primary and secondary antibodies were diluted in the same blocking buffer. Primary antibodies were incubated at 4°C overnight, and secondary antibodies were incubated for 2 h at room temperature. All washing steps were performed with PBS, and DAPI at 1 μg/ml was used to stain DNA. Epicardial explants (see later description) were fixed with 4% Formalin and processed as described. Antibodies used in this study are indicated next.

Antibodies
----------

Antibodies used and their respective dilutions are as follows. Rabbit anti-Wt1 (sc-192, 1:20; Santa Cruz Biotechnology, Santa Cruz, CA), rabbit anti-CD31 (ab28364, 1:50; Abcam, Cambridge, MA), mouse anti--smooth muscle actin, α-Cy3 (C6198, 1:100; Sigma-Aldrich, St. Louis, MO), rat anti--ZO-1 (R26.4C-c, 1:50; Developmental Studies Hybridoma Bank, Iowa City, IA), and mouse anti--lamin A/C (39287, 1:100; Active Motif, Carlsbad, CA). Alexa Fluor--conjugated secondary antibodies (1:1000) were either goat anti-rabbit or rat and are available from Invitrogen/Molecular Probes.

Imaging
-------

Hematoxylin and eosin--stained sections were imaged with a Leica M125 microscope using Leica LAS EZ software. Immunofluorescence imaging was done using a Leica SP5 laser-scanning confocal microscope using Leica LAS AF software. Bright-field imaging of epicardial explant for cell number quantitation was done using a Nikon Eclipse TE200 inverted microscope. Live imaging of epicardial explants used in the wound-healing assay was done using a Nikon Eclipse TE2000U equipped with a Pathology Devices LiveCell controller for temperature, humidity, and CO~2~ regulation. MetaMorph was used for the wide-field microscopes. The Multidimensional Acquisition plug-in for MetaMorph was used for live imaging. Images were analyzed with either MetaMorph or the FIJI package of ImageJ.

Epicardial explants
-------------------

Epicardial explant was done in a manner similar to that previously described but with modifications ([@B1]). Hearts from E12.5 embryos were isolated, and atria were removed with forceps (11251-20; Fine Science Tools). The remaining ventricles were placed in a gelatinized well of a 24-well plate containing 200 μl of DMEM supplemented with 10% fetal bovine serum, glutaMAX, and penicillin/streptomycin ("explant media"). The orientation of the heart was such that dorsal portion was on the surface of the well. Explant culture was done for 48 h at 37°C with 5% oxygen. After this initial culture, the heart was removed, and the remaining explant was washed with PBS. Explants were then grown for an additional 72 h in explant media before any other subsequent procedures. For immunofluorescence of epicardial explants, the heart was placed on a gelatinized circular coverglass (12-545-80; Fisher) in a 24-well plate, and the foregoing procedures were followed.

Wound-healing assay
-------------------

The wound-healing assay was performed as previously described but with modification ([@B47]). Epicardial explants were scratched with a sterile 10-μl pipet tip, followed by washing with PBS. Explant medium was added, and the wound was imaged as described in the *Imaging* section at the indicated time points. The amount of wound closure was measured by quantitating the intervening area with ImageJ 1.46r software. Graphical representation is the mean ± SD from three independent experiments.

Transwell chamber assay
-----------------------

Multiple epicardial explants of the same genotype were pooled and counted with a hemocytometer. Approximately 20,000 epicardial cells of the indicated genotype were seeded in a 100-μl volume of explant medium in the upper chamber of the Transwell apparatus (351163; BD, San Jose, CA). The lower chamber contained a 150-μl volume of explant medium. The culture was then incubated for 24 h at 37°C with 5% oxygen. Afterward, the insert was removed, and the original seeding was detached with a cotton swab. The insert was then fixed in 4% Formalin, permeabilized, and stained with DAPI, and the cells that had migrated to the opposite side of the insert were imaged by confocal microscopy. Quantitation is presented as a ratio relative to wild type ± SD.

RNA-sequencing
--------------

Total epicardial cell RNA was isolated using the Arcturus PicoPure RNA (Invitrogen) isolation kit according to the manufacturer's instruction. Libraries were constructed using the Illumina TrueSeq RNA library kit, version 2.0, and sequenced using an Illumina HiSeq 2000. Reads were mapped using Bowtie 2.0, and expression was analyzed using the Cufflinks package. Genes with RPKM (reads per kilobase of transcript per million mapped reads) \< 2 were discarded. Further analysis was done in R using the EdgeR library. Charts were produced using Excel (Microsoft). GO term analysis was performed using the DAVID web interface (National Institutes of Health; <https://david.ncifcrf.gov/>). RNA-sequencing data are available (GEO accession GSE87344; [www.ncbi.nlm.nih.gov/geo/](http://www.ncbi.nlm.nih.gov/geo/)). Validation of RNA-sequencing data was done by qRT-PCR using iQ Sybr Green Mastermix (Bio-Rad) on a Bio-Rad CFX96 Real Time System.
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